KalVista Pharmaceuticals News

KalVista Pharmaceuticals | 8-K: Current report

Apr 23 04:58

KalVista Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Fairey William

Apr 23 04:42

KalVista Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-Director Fairey William

Apr 23 04:38

KalVista Pharmaceuticals | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-TCG Crossover GP I, LLC(3.2%),TCG Crossover Fund I, L.P.(3.2%), etc.

Apr 2 04:19

KalVista Pharmaceuticals | 8-K: KalVista Pharmaceuticals Reports Third Fiscal Quarter Results and Provides Operational Update

Mar 12 04:45

KalVista Pharmaceuticals | 10-Q: Quarterly report

Mar 12 04:28

KalVista Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Palleiko Benjamin L

Mar 9 05:52

KalVista Pharmaceuticals | 8-K: Current report

Mar 7 19:39

KalVista Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-Adage Capital Partners, L.P.(6.87%),Adage Capital Partners GP, L.L.C.(6.87%), etc.

Feb 27 05:44

KalVista Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-10% Owner Venrock Healthcare Capital Partners III, L.P.

Feb 23 05:17

KalVista Pharmaceuticals | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-James N. Topper(8.9%),Patrick J. Heron(8.9%), etc.

Feb 23 02:27

KalVista Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Feener Edward P.

Feb 22 10:52

KalVista Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Yea Christopher

Feb 22 10:52

KalVista Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Palleiko Benjamin L

Feb 22 10:52

KalVista Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Audhya Paul K.

Feb 22 10:47

KalVista Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Crockett Thomas Andrew

Feb 22 10:47

KalVista Pharmaceuticals | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-TCG Crossover GP I, LLC(6.52%),TCG Crossover Fund I, L.P.(6.52%), etc.

Feb 21 05:54

KalVista Pharmaceuticals | 8-K: Current report

Feb 17 05:40

KalVista Pharmaceuticals | 424B5: Prospectus

Feb 17 05:32

KalVista Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Yea Christopher

Feb 17 05:25